| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Cancer Research and Treatment Search > Browse Articles > Search



Diagnostic Significance of p38 Isoforms (p38α, p38β, p38γ, p38δ) in Head and Neck Squamous Cell Carcinoma: Comparative Serum Level Evaluation and Design of Novel Peptide Inhibitor Targeting the Same
Vishal Sahu, Lokesh Nigam, Vertica Agnihotri, Abhishek Gupta, Shashank Shekhar, Naidu Subbarao, Suman Bhaskar, Sharmistha Dey
Cancer Res Treat. 2019;51(1):313-325.   Published online May 9, 2018    DOI: https://doi.org/10.4143/crt.2018.105
                              Supplementary      
Profiling of Serum Metabolites Using MALDI-TOF and Triple-TOF Mass Spectrometry to Develop a Screen for Ovarian Cancer
Jun Hwa Lee, Yun Hwan Kim, Kyung-Hee Kim, Jae Youl Cho, Sang Myung Woo, Byong Chul Yoo, Seung Cheol Kim
Cancer Res Treat. 2018;50(3):883-893.   Published online September 18, 2017    DOI: https://doi.org/10.4143/crt.2017.275
                              Supplementary      
Pretreatment Serum Amyloid A and C-reactive Protein Comparing with Epstein-Barr Virus DNA as Prognostic Indicators in Patients with Nasopharyngeal Carcinoma: A Prospective Study
Qiu-Yan Chen, Qing-Nan Tang, Lin-Quan Tang, Wen-Hui Chen, Shan-Shan Guo, Li-Ting Liu, Chao-Feng Li, Yang Li, Yu-Jing Liang, Xue-Song Sun, Ling Guo, Hao-Yuan Mo, Rui Sun, Dong-Hua Luo, Yu-Ying Fan, Yan He, Ming-Yuan Chen, Ka-Jia Cao, Chao-Nan Qian, Xiang Guo, Hai-Qiang Mai
Cancer Res Treat. 2018;50(3):701-711.   Published online July 14, 2017    DOI: https://doi.org/10.4143/crt.2017.180
                              Supplementary      
Can Serum be Used for Analyzing the KRAS Mutation Status in Patients with Advanced Colorectal Cancer?
Seung Tae Kim, Won Jin Chang, Lihua Jin, Jae Sook Sung, Yun Ji Choi, Yeul Hong Kim
Cancer Res Treat. 2015;47(4):796-803.   Published online January 30, 2015    DOI: https://doi.org/10.4143/crt.2014.106
                                 Cited By 2
Prognostic Significance of Serum and Tissue Carcinoembryonic Antigen in Patients with Gastric Adenocarcinomas
Seong-Hoon Park, Ki-Beom Ku, Ho-Young Chung, Wansik Yu
Cancer Res Treat. 2008;40(1):16-21.   Published online March 31, 2008    DOI: https://doi.org/10.4143/crt.2008.40.1.16
                                 Cited By 12
Serum HER2 as a Response Indicator to Various Chemotherapeutic Agents in Tissue HER2 Positive Metastatic Breast Cancer
Sun-Young Kong, Do Hoon Lee, Eun Sook Lee, Susan Park, Keun Seok Lee, Jungsil Ro
Cancer Res Treat. 2006;38(1):35-39.   Published online February 28, 2006    DOI: https://doi.org/10.4143/crt.2006.38.1.35
                                 Cited By 9
Clinical Significance of Urokinase-type Plasminogen Activator (uPA) Expression from Serum and Tissue of Gastric Cancer Patients
Hyun Cheol Chung, Joon Oh Park, Hyun Ja Kwon, Tae Soo Kim, Hei Cheol Chung, Soo Jung Gong, Hwa Young Lee, Sun Young Rha, Nae Choon Yoo, Joo Hang Kim, Jae Kyung Roh, Sung Hoon Noh, Jin Sik Min, Byung Soo Kim
J Korean Cancer Assoc. 1997;29(5):765-773.
      
Short Term Culture and Cytogenetic Analysis of Human Breast Cancer
Sun Hwa Park, Yong Huch Chun, Jeoung Won Bae
J Korean Cancer Assoc. 1995;27(3):426-436.
      
Serum Insulin - like Growth Factor Binding Proteins profiles in Hepatocelllular Carcinoma
Dae Yeol Lee, Dae Gon Kim, Jung Soo Kim
J Korean Cancer Assoc. 1995;27(2):238-247.
      
Detection of Soluble c-erbB-2 Oncoproteins in the Serum of Gastric Cnacer patients as a Tumor Marker
Hyung Cheol Chung, Joong Bae Ahn, Joon Oh Park, Jae Yong Cho, Sun Young Rha, Chong In Lee, Hye Ran Lee, Nae Choon Yoo, Joo Hang Kim, Jae Kyung Roh, Sung Hoon Noh, Jin Sik Min, Byung Soo Kim, Ho Yeon
J Korean Cancer Assoc. 1995;27(2):175-184.
      
Serum Effect on the Indurtive Phase and Cytotoxic Phase of Lymphockine - activated Killer Cell
Oh Hoong Kwon, Jin Pok Kim
J Korean Cancer Assoc. 1989;21(2):339-354.
      
Albumin-to-Fibrinogen Ratio as an Independent Prognostic Parameter in Untreated Chronic Lymphocytic Leukemia: A Retrospective Study of 191 Cases
Yi-Xin Zou, Jia Qiao, Hua-Yuan Zhu, Rui-Nan Lu, Yi Xia, Lei Cao, Wei Wu, Hui Jin, Wen-Jie Liu, Jin-Hua Liang, Jia-Zhu Wu, Li Wang, Lei Fan, Wei Xu, Jian-Yong Li
Received June 14, 2018   Accepted July 31, 2018   Published online August 1, 2018
DOI: https://doi.org/10.4143/crt.2018.358    
[Epub ahead of print]
                              
Korean Cancer Association
E-Submission
EndNote Output Style
Email Alert
Cancer Research and Treatment 2017; 49(4): 915-926.
Impact factor
SCImago Journal & Country Rank
PubMed Central
MEDLINE/PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
COPE
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association. All rights reserved.                 Developed in M2Community